Treatment Of Posttraumatic Stress Disorder With Tiagabine
Dear Editor:
Posttraumatic stress disorder (PTSD) can be a debilitating condition with impairment as bad as, or worse than, that caused by other psychiatric illnesses (1) . Symptomatology includes a triad of symptoms from 3 clusters: persistent reexperiencing of the trauma (for example, intrusive and distressing recollections, nightmares, and dissociative flashbacks); persistent avoidance of stimuli associated with the trauma; and persistent symptoms of increased autonomic arousal (2) . Because the symptoms of PTSD can vary across the symptom clusters, medications from different classes are needed to treat patients. Based on the hypothesis that kindling of the limbic nuclei occurs following the trauma (3) (4) (5) , anticonvulsants such as carbamezapine and valproate were used to treat PTSD as far back as the mid-1980s to the early 1990s, (6, 7) . Newer anticonvulsants such as lamotrigene, gabapentin, and topiramate have also been used (8) (9) (10) .
I present the case of a patient diagnosed with PTSD and major depressive disorder (MDD) who had taken multiple medications in the past and received benefit from tiagabine. To date, there are no reports in the literature describing the use of tiagabine to treat PTSD.
Case Report
Mr A is a 43-year-old man with a history of PTSD and MDD. His illness caused significant impairment over the years, and he had been treated with the following agents: sertraline, paroxetine, fluoxetine, buproprion augmented with lithium, trazadone, nefazodone, gabapentin, and topiramate.
Upon consultation, Mr A agreed to a trial of venlafaxine extended release (XR), started at 37.5 mg daily and titrated to 225 mg daily over 3 weeks. After 1 month, he noted an improvement in his depressive symptoms, but he was still experiencing intrusive thoughts, nightmares, and hypervigilance. He agreed to a trial of tiagabine, initiated at 2 mg daily. His dosage was increased by weekly 2 mg increments to 8 mg daily, at which level he began to notice an improvement in his intrusive thoughts and nightmares-even through the traumatic events of September 11, 2001 , which provided a flood of external cues. He occasionally takes zolpidem tartrate 10 mg for insomnia, but over the past 6 months he has improved significantly, to the point of returning to work full-time. He cannot recall feeling this stable during the last 10 years.
Tiagabine is FDA-approved as an adjunct anticonvulsant for the treatment of partial seizures (11) . It is thought to exert its action by inhibiting GABA from the synaptic cleft (12, 13) . Tiagabine has also been shown to have antikindling potency (14) , making it a potential candidate in treating PTSD. This patient's improvement might have been due to a combination of agents, but the addition of tiagabine clearly led to a reduction in the reexperiencing symptoms. Further controlled studies are needed to investigate the efficacy of tiagabine in treating PTSD. evidence suggesting psychological (3), biological (4), and pharmacologic (5) explanations. Regardless of its etiology, however, the careful assessment of how pain tolerance interacts with delusional ideation in patients recently hospitalized during an acute psychotic episode cannot be stressed enough. Simply diagnosing and assessing for psychotic symptomatology is not adequate. Failure to adequately assess the intricacies of a patient's delusion system and pain sensitivity can result in serious medical consequences. The following case report will illustrate this important matter.
Mr A is a 38-year-old Haitian-American with a 16-year history of schizoaffective disorder. He was admitted to an inpatient psychiatric hospital during his most recent psychotic episode.When admitted, Mr A was experiencing auditory command hallucinations and suicidal ideation. His command hallucinations were instructing him to commit suicide by overdosing on his prescribed neuroleptic (haloperidol) while consuming alcohol. He denied previous substance-abuse issues. Fifteen years earlier, he had followed command hallucinations to self-amputate his penis as a punishment for not yet having had sexual intercourse. During his most recent hospitalization, he complained to the nursing staff about problems with urination. (Although difficulties with urination can occur as a result of penile amputation, he had not reported any prior difficulty.) When evaluated after this complaint, the patient reported that his problems with urination had ceased and that he was able to urinate adequately without difficulty. However, although he initially denied any problems, a careful inquiry revealed that he was also experiencing mild abdominal pain which had commenced after he had experienced auditory hallucinations a few hours earlier. During this inquiry, the patient admitted to additional command hallucinations instructing him to "make [his testicles] numb." He reported that the auditory hallucinations instructed him to squeeze his testicles. Since squeezing did not provide adequate numbness, he subsequently tied the top of his scrotum with a shoelace, which he had not yet untied. A physical examination revealed a shoelace tied around the apical part of the scrotum. The shoelace was then subsequently cut. A sonogram revealed a hydrocele of the testicles, which might eventually have led to vascular necrosis.
Discussion
In this case report, the patient's ability to minimize his experience of pain and the consequences of his behaviour could have led to severe medical repercussions. During an acute psychotic episode, patients can experience significantly increased pain thresholds, a factor that should be considered as part of a complete assessment of delusional ideation. In this case, failure to thoroughly assess the extent of this patient's delusion and pain threshold might have resulted in the loss of his testicles. Further research investigating the etiology and epidemiology of increased pain tolerance in patients with psychosis will improve assessments in this area and may also help to prevent serious medical consequences.
